Development of Novel Amino-Quinoline-5,8-dione Derivatives As NAD(P)H:quinone Oxidoreductase 1 (NQO1) Inhibitors with Potent Antiproliferative Activities
Yong Ling,Qiu-Xing Yang,Yu-Ning Teng,Shi Chen,Wei-Jie Gao,Jing Guo,Pei-Ling Hsu,Yue Liu,Susan L. Morris-Natschke,Chin-Chuan Hung,Kuo-Hsiung Lee
DOI: https://doi.org/10.1016/j.ejmech.2018.05.025
IF: 7.088
2018-01-01
European Journal of Medicinal Chemistry
Abstract:Fourteen novel amino-quinoline-5,8-dione derivatives (6a-h and 7a-h) were designed and synthesized by coupling different alkyl- or aryl-amino fragments at the C6- or C7-position of quinoline-5,8-dione. All target compounds showed antiproliferative potency in the low micromolar range in both drug sensitive HeLaS3 and multidrug resistant KB-vin cell lines. Compounds 6h, 6d, 7a, and 7d exhibited more potent antiproliferative effects than the other compounds. Especially, compounds 6d and 7d displayed NQO1-dependent cytotoxicity and competitive NQO1 inhibitory effects in both drug sensitive HeLaS3 and multidrug resistant KB-vin cell lines. Furthermore, compounds 6h, 6d, 7a, and 7d induced a dose-dependent lethal mitochondrial dysfunction in both drug sensitive HeLaS3 and multidrug resistant KB-vin cells by increasing intracellular reactive oxygen species (ROS) levels. Notably, compound 7d selectively inhibited cancer cells, but not non-tumor liver cell proliferation in vitro, and significantly triggered HeLaS3 cell apoptosis by regulating apoptotic proteins of Bcl-2, Bax, and cleaved caspase-3 in a dose-dependent manner. Our findings suggest that these novel C6- or C7-substituted amino-quinoline-5,8-dione derivatives, such as 7d, could be further developed in the future as potent and selective antitumor agents to potentially circumvent multi-drug resistance (MDR).